Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Oncolytics Biotech Inc
T.ONC
Alternate Symbol(s):
ONCY
Healthcare
Biotechnology
Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune...
responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to phase 3 licensure-enabling studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:ONC)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
...
Next
(48)
•••
spesestsemper
X
View Profile
View Bullboard History
Comment by
spesestsemper
on Apr 23, 2024 12:43pm
RE:RE:RE:RE:RE:short interest
thanks for the info . That is interesting . The shares would have to be over $9 canadian for 20 days for them to do this then .
(299)
•••
inthno
X
View Profile
View Bullboard History
Comment by
inthno
on Apr 23, 2024 12:18pm
RE:RE:RE:RE:short interest
It is true that oncy can call the warrants anytime in the 60 month time frame under the following conditions as noted by the following from the warrant agreement.... The expiry of the Warrants may be
...more
Strong Q1 and Muscular Q2 Outlook for Cannabis Edibles Leader
posted May 25, 2024 9:00am by
Indiva Ltd
-
|
Gross revenue Q1 was $10.6 million, a 2.6% increase YOY as the company replaced over 50% of its net revenue from Wana’s shift to contract manufacturing and a regulatory change with its own core brands, namely Pearls gummies. Post Q1, April 2024 was a record month for net revenue, with growth driven by continued strength in Pearls, revenue from No Future gummies and Indiva Blips ...read more
(1409)
•••
Azzak34
X
View Profile
View Bullboard History
Comment by
Azzak34
on Apr 23, 2024 12:01pm
RE:RE:RE:RE:RE:RE:RE:PwC sees continuation of US$ 5 to 15 Billion Bio M&A Deals
Haha Bucky is the counterbalance?!? That's like a seesaw with an elephant on one side and a gnat on the other..... a very, very dumb gnat. You Sir, are ridiculous.
(196)
•••
Buckhenry
X
View Profile
View Bullboard History
Comment by
Buckhenry
on Apr 23, 2024 11:56am
RE:RE:RE:RE:RE:RE:PwC sees continuation of US$ 5 to 15 Billion Bio M&A Deals
Me and canuckfan have something in common... sorda... my motive is to balance out the worthless postings by the forever pumpers. Loved unnoteable's "repost" the other day
...more
(5814)
•••
Noteable
X
View Profile
View Bullboard History
Comment by
Noteable
on Apr 23, 2024 11:46am
RE:RE:RE:short interest
ONCY can call the warrants at ONCY's discretion at any time before the 60 months. Read the agreement.
(5814)
•••
Noteable
X
View Profile
View Bullboard History
Comment by
Noteable
on Apr 23, 2024 11:37am
RE:RE:RE:RE:PD-(L)1 checkpoint inhibitors to reach $58 Billion by 2025
Very typical stock price action -- CrF posts and the price goes down.
(5814)
•••
Noteable
X
View Profile
View Bullboard History
Comment by
Noteable
on Apr 23, 2024 11:35am
RE:RE:RE:PD-(L)1 checkpoint inhibitors to reach $58 Billion by 2025
Pelareorep's life cycle managment is to first to pair pelareorep + with an IV immune checkpoint inhibitor, thus bestowing pelareorep's 13 years of exclusivity on to the IV ICI (which are about
...more
(956)
•••
canadafan
X
View Profile
View Bullboard History
Comment by
canadafan
on Apr 23, 2024 11:32am
RE:RE:RE:PD-(L)1 checkpoint inhibitors to reach $58 Billion by 2025
Regarding the short question. Not my bag at all. Never have shorted, never will. imho, the whole process should be banned as it is in some countries. Saying that. I'm not certain,but I believe
...more
(5814)
•••
Noteable
X
View Profile
View Bullboard History
Comment by
Noteable
on Apr 23, 2024 11:23am
RE:RE:RE:EU Legislative proposals aims to expedite new medicines
Last week's international adoption of the expedited approval process of biologics drugs that address orphan diseases and those diseases (i.e. cancers) with "unmet treatment needs"
...more
(5814)
•••
Noteable
X
View Profile
View Bullboard History
Comment by
Noteable
on Apr 23, 2024 11:03am
RE:RE:PD-(L)1 checkpoint inhibitors to reach $58 Billion by 2025
Roche's acquisition of the marketing approval of tecentriq SC in Canada, could now be the catalyst for Roche to make its move on ONCY, thus prompting other bidders to escalate their M&A
...more
(5814)
•••
Noteable
X
View Profile
View Bullboard History
Comment by
Noteable
on Apr 23, 2024 10:54am
RE:RE:RE:short interest
ONCY had issued US$15 Million of callable warrants to Anson at US$2.91 per share, which means that Anson has limited upside risk on its short position and ONCY has an additional pool of US$15 million
...more
(1409)
•••
Azzak34
X
View Profile
View Bullboard History
Comment by
Azzak34
on Apr 23, 2024 10:50am
RE:RE:short interest
As long as we hover around here the premium to hold their position becomes less appealing. There are certainly better short opportunities out there. As notable said it may well be Anson playing
...more
(48)
•••
spesestsemper
X
View Profile
View Bullboard History
Comment by
spesestsemper
on Apr 23, 2024 10:48am
RE:RE:short interest
Was this the private placement they did ? 2023-08-08 | TSX:ONC | Press Release | Oncolytics Biotech Inc (stockhouse.com) So , they have 60 months for the warrants - would they use them to cover
...more
(5814)
•••
Noteable
X
View Profile
View Bullboard History
Comment by
Noteable
on Apr 23, 2024 10:46am
RE:RE:short interest
bruce winson
Prev
...
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >